Literature DB >> 21117578

The efficacy of low-energy selective laser trabeculoplasty.

Min Tang1, Yang Fu, Ming-Shui Fu, Ying Fan, Hai-Dong Zou, Xiao-Dong Sun, Xun Xu.   

Abstract

BACKGROUND AND
OBJECTIVE: to analyze the efficacy of low-energy selective laser trabeculoplasty (SLT) in patients. PATIENTS AND METHODS: in 74 patients (74 eyes) with ocular hypertension, suspected glaucoma, or primary open-angle glaucoma, SLT was the first-choice treatment. Thirty-nine patients in the low-energy group received treatment using half of conventional laser energy over 360° of the trabecular meshwork (at 100 points). Thirty-five patients in the control group received conventional laser energy. Patients were observed for 1 year. Complications and intraocular pressure (IOP) were observed.
RESULTS: postoperative transient IOP spike (≥ 3 mm Hg) occurred in three eyes on the day of treatment and partial peripheral anterior synechiae occurred in one eye 1 month after treatment only in the control group. Effective rates of treatment (≥ 20% IOP reduction) at week 2 and month 1, 3, 6, and 12 after treatment were 69.23%, 64.10%, 61.54%, 53.85%, and 48.72% in the low-energy group and 71.43%, 71.43%, 60%, 51.43%, and 48.57% in the control group, respectively. There was no statistically significant difference between the two groups at various time points (P = .836, .501, .892, .835, .990).
CONCLUSION: compared with SLT using conventional laser energy, low-energy SLT lowers IOP with fewer complications, making it a safe and effective option.

Entities:  

Mesh:

Year:  2010        PMID: 21117578     DOI: 10.3928/15428877-20101124-07

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers Imaging        ISSN: 1542-8877


  12 in total

Review 1.  Selective laser trabeculoplasty: past, present, and future.

Authors:  A Garg; G Gazzard
Journal:  Eye (Lond)       Date:  2018-01-05       Impact factor: 3.775

Review 2.  Laser trabeculoplasty for open-angle glaucoma and ocular hypertension.

Authors:  Christiane R Rolim-de-Moura; Augusto Paranhos; Mohamed Loutfi; David Burton; Richard Wormald; Jennifer R Evans
Journal:  Cochrane Database Syst Rev       Date:  2022-08-09

Review 3.  A Review of Selective Laser Trabeculoplasty: "The Hype Is Real".

Authors:  Tomislav Sarenac; Anela Bečić Turkanović; Peter Ferme; Tomaž Gračner
Journal:  J Clin Med       Date:  2022-07-04       Impact factor: 4.964

4.  Towards Automatically Controlled Dosing for Selective Laser Trabeculoplasty.

Authors:  Katharina Bliedtner; Eric Seifert; Ralf Brinkmann
Journal:  Transl Vis Sci Technol       Date:  2019-12-02       Impact factor: 3.283

5.  Low-energy Selective Laser Trabeculoplasty Repeated Annually: Rationale for the COAST Trial.

Authors:  Tony Realini; Gus Gazzard; Mark Latina; Michael Kass
Journal:  J Glaucoma       Date:  2021-07-01       Impact factor: 2.290

6.  Ultrastructural Changes in Human Trabecular Meshwork Tissue after Laser Trabeculoplasty.

Authors:  Jeffrey R SooHoo; Leonard K Seibold; David A Ammar; Malik Y Kahook
Journal:  J Ophthalmol       Date:  2015-05-12       Impact factor: 1.909

Review 7.  Selective laser trabeculoplasty: current perspectives.

Authors:  Kate E Leahy; Andrew Jr White
Journal:  Clin Ophthalmol       Date:  2015-05-11

8.  Selective laser trabeculoplasty for early glaucoma: analysis of success predictors and adjusted laser outcomes based on the untreated fellow eye.

Authors:  Mikael Chun; Carolina P B Gracitelli; Flavio S Lopes; Luis G Biteli; Michele Ushida; Tiago S Prata
Journal:  BMC Ophthalmol       Date:  2016-11-23       Impact factor: 2.209

Review 9.  Complications of selective laser trabeculoplasty: a review.

Authors:  Julia Song
Journal:  Clin Ophthalmol       Date:  2016-01-14

10.  Intraocular Pressure-Lowering Potential of Subthreshold Selective Laser Trabeculoplasty in Patients with Primary Open-Angle Glaucoma.

Authors:  Hong Yang Zhang; Yong Jie Qin; Yang Fan Yang; Jian Gang Xu; Min Bin Yu
Journal:  J Ophthalmol       Date:  2016-07-27       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.